Price T Rowe Associates Inc Insmed Inc Transaction History

Price T Rowe Associates Inc

$883 Billion
Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Insmed Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 11,230,705 shares of INSM stock, worth $1.61 Billion. This represents 0.13% of its overall portfolio holdings.

Number of Shares

11,230,705

Previous 12,923,541 13.1%

Holding current value

$1.61 Billion

Previous $986 Million 14.64%

% of portfolio

0.13%

Previous 0.12%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$64.81 - $105.9 $110 Million - $179 Million	-1,692,836 Reduced 13.1%	11,230,705 $1.13 Billion
Q1 2025 May 14, 2025	BUY	$65.25 - $83.83 $14.3 Million - $18.4 Million	219,131 Added 1.72%	12,923,541 $986 Million
Q4 2024 Feb 14, 2025	BUY	$66.29 - $76.63 $8.18 Million - $9.46 Million	123,429 Added 0.98%	12,704,410 $877 Million
Q3 2024 Nov 14, 2024	BUY	$62.0 - $79.01 $25.9 Million - $33 Million	417,613 Added 3.43%	12,580,981 $918 Million
Q2 2024 Aug 14, 2024	BUY	$22.0 - $69.71 $30.7 Million - $97.2 Million	1,394,002 Added 12.94%	12,163,368 $815 Million
Q1 2024 May 15, 2024	BUY	$25.72 - $29.94 $143,903 - $167,514	5,595 Added 0.05%	10,769,366 $292 Million
Q4 2023 Feb 14, 2024	BUY	$23.42 - $31.74 $8.35 Million - $11.3 Million	356,555 Added 3.43%	10,763,771 $334 Million
Q3 2023 Nov 14, 2023	BUY	$19.86 - $26.93 $4.67 Million - $6.33 Million	234,920 Added 2.31%	10,407,216 $263 Million
Q2 2023 Aug 14, 2023	BUY	$16.44 - $21.1 $3.13 Million - $4.01 Million	190,232 Added 1.91%	10,172,296 $215 Million
Q1 2023 May 15, 2023	BUY	$16.26 - $21.73 $67,527 - $90,244	4,153 Added 0.04%	9,982,064 $170 Million
Q4 2022 Feb 14, 2023	BUY	$16.98 - $23.15 $7.3 Million - $9.95 Million	429,664 Added 4.5%	9,977,911 $199 Million
Q3 2022 Nov 14, 2022	SELL	$20.88 - $28.21 $139 Million - $188 Million	-6,674,376 Reduced 41.14%	9,548,247 $206 Million
Q2 2022 Aug 15, 2022	BUY	$17.07 - $25.71 $6.22 Million - $9.37 Million	364,362 Added 2.3%	16,222,623 $320 Million
Q1 2022 May 16, 2022	BUY	$20.42 - $28.13 $11 Million - $15.1 Million	537,057 Added 3.51%	15,858,261 $373 Million
Q4 2021 Feb 14, 2022	BUY	$25.89 - $33.45 $15 Million - $19.4 Million	580,772 Added 3.94%	15,321,204 $417 Million
Q3 2021 Nov 15, 2021	BUY	$22.46 - $29.47 $8.26 Million - $10.8 Million	367,747 Added 2.56%	14,740,432 $406 Million
Q2 2021 Aug 16, 2021	BUY	$24.17 - $36.01 $74.2 Million - $111 Million	3,070,140 Added 27.16%	14,372,685 $409 Million
Q1 2021 May 17, 2021	BUY	$32.28 - $44.3 $53.3 Million - $73.1 Million	1,650,241 Added 17.1%	11,302,545 $385 Million
Q4 2020 Feb 16, 2021	BUY	$31.45 - $40.54 $304 Million - $391 Million	9,652,304 New	9,652,304 $321 Million

Others Institutions Holding INSM

# of Institutions

579

Shares Held

203M

Call Options Held

2.84M

Put Options Held

3.26M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $19.4B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Insmed Inc Transaction History